Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 83

1.

A systematic review of the relationship between behavioral and psychological symptoms (BPSD) and caregiver well-being.

Feast A, Moniz-Cook E, Stoner C, Charlesworth G, Orrell M.

Int Psychogeriatr. 2016 Jun 27:1-14. [Epub ahead of print]

PMID:
27345942
2.

A biopsychosocial vignette for case conceptualization in dementia (VIG-Dem): development and pilot study.

Spector A, Hebditch M, Stoner CR, Gibbor L.

Int Psychogeriatr. 2016 Sep;28(9):1471-80. doi: 10.1017/S1041610216000338. Epub 2016 Apr 7.

PMID:
27053356
3.

Review of Positive Psychology Outcome Measures for Chronic Illness, Traumatic Brain Injury and Older Adults: Adaptability in Dementia?

Stoner CR, Orrell M, Spector A.

Dement Geriatr Cogn Disord. 2015;40(5-6):340-57. doi: 10.1159/000439044. Epub 2015 Sep 25. Review.

4.

The Social N400 effect: how the presence of other listeners affects language comprehension.

Rueschemeyer SA, Gardner T, Stoner C.

Psychon Bull Rev. 2015 Feb;22(1):128-34. doi: 10.3758/s13423-014-0654-x.

PMID:
24825307
5.

Discovery of a series of imidazo[4,5-b]pyridines with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ.

Casimiro-Garcia A, Filzen GF, Flynn D, Bigge CF, Chen J, Davis JA, Dudley DA, Edmunds JJ, Esmaeil N, Geyer A, Heemstra RJ, Jalaie M, Ohren JF, Ostroski R, Ellis T, Schaum RP, Stoner C.

J Med Chem. 2011 Jun 23;54(12):4219-33. doi: 10.1021/jm200409s. Epub 2011 May 26.

PMID:
21557540
6.

Integrated in silico-in vitro strategy for addressing cytochrome P450 3A4 time-dependent inhibition.

Zientek M, Stoner C, Ayscue R, Klug-McLeod J, Jiang Y, West M, Collins C, Ekins S.

Chem Res Toxicol. 2010 Mar 15;23(3):664-76. doi: 10.1021/tx900417f.

PMID:
20151638
7.
8.

Discovery of a novel class of targeted kinase inhibitors that blocks protein kinase C signaling and ameliorates retinal vascular leakage in a diabetic rat model.

Grant S, Tran P, Zhang Q, Zou A, Dinh D, Jensen J, Zhou S, Kang X, Zachwieja J, Lippincott J, Liu K, Johnson SL, Scales S, Yin C, Nukui S, Stoner C, Prasanna G, Lafontaine J, Wells P, Li H.

Eur J Pharmacol. 2010 Feb 10;627(1-3):16-25. doi: 10.1016/j.ejphar.2009.10.029. Epub 2009 Oct 20.

PMID:
19850035
9.

Effect of thioredoxin deletion and p53 cysteine replacement on human p53 activity in wild-type and thioredoxin reductase null yeast.

Stoner CS, Pearson GD, Koç A, Merwin JR, Lopez NI, Merrill GF.

Biochemistry. 2009 Sep 29;48(38):9156-69. doi: 10.1021/bi900757q.

10.

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.

Pratley RE, Reusch JE, Fleck PR, Wilson CA, Mekki Q; Alogliptin Study 009 Group.

Curr Med Res Opin. 2009 Oct;25(10):2361-71. doi: 10.1185/03007990903156111.

PMID:
19650752
11.

Synthesis and SAR of tolylamine 5-HT6 antagonists.

Singer JM, Wilson MW, Johnson PD, Graham SR, Cooke LW, Roof RL, Boxer PA, Gold LH, Meltzer LT, Janssen A, Roush N, Campbell JE, Su TZ, Hurst SI, Stoner CL, Schwarz JB.

Bioorg Med Chem Lett. 2009 May 1;19(9):2409-12. doi: 10.1016/j.bmcl.2009.03.077. Epub 2009 Mar 25.

PMID:
19346128
12.

The development and validation of a computational model to predict rat liver microsomal clearance.

Chang C, Duignan DB, Johnson KD, Lee PH, Cowan GS, Gifford EM, Stankovic CJ, Lepsy CS, Stoner CL.

J Pharm Sci. 2009 Aug;98(8):2857-67. doi: 10.1002/jps.21651.

PMID:
19116953
13.
14.

Clinical predictors of left atrial thrombus and spontaneous echocardiographic contrast in patients with atrial fibrillation.

Rader VJ, Khumri TM, Idupulapati M, Stoner CN, Magalski A, Main ML.

J Am Soc Echocardiogr. 2007 Oct;20(10):1181-5. Epub 2007 Jun 12.

PMID:
17566700
15.

Clinical and echocardiographic markers of mortality risk in patients with atrial fibrillation.

Khumri TM, Idupulapati M, Rader VJ, Nayyar S, Stoner CN, Main ML.

Am J Cardiol. 2007 Jun 15;99(12):1733-6. Epub 2007 Apr 26.

PMID:
17560884
16.

Assessment of effectiveness of protection strategies in Tanzania based on a decade of survey data for large herbivores.

Stoner C, Caro T, Mduma S, Mlingwa C, Sabuni G, Borner M.

Conserv Biol. 2007 Jun;21(3):635-46.

PMID:
17531042
17.

Self-reported use of complementary and alternative medicine in patients with previous acute coronary syndrome.

Decker C, Huddleston J, Kosiborod M, Buchanan DM, Stoner C, Jones A, Banerjee S, Spertus JA.

Am J Cardiol. 2007 Apr 1;99(7):930-3. Epub 2007 Feb 15.

PMID:
17398186
18.

Usefulness of myocardial contrast echocardiography in predicting late mortality in patients with anterior wall acute myocardial infarction.

Khumri TM, Nayyar S, Idupulapati M, Magalski A, Stoner CN, Kusnetzky LL, Kosiborod M, Spertus JA, Main ML.

Am J Cardiol. 2006 Nov 1;98(9):1150-5. Epub 2006 Aug 31.

PMID:
17056316
19.

Contrast administration reduces interobserver variability in determination of left ventricular ejection fraction in patients with left ventricular dysfunction and good baseline endocardial border delineation.

Nayyar S, Magalski A, Khumri TM, Idupulapati M, Stoner CN, Kusnetzky LL, Coggins TR, Morris BA, Main ML.

Am J Cardiol. 2006 Oct 15;98(8):1110-4. Epub 2006 Aug 31.

PMID:
17027582
20.

The road map to oral bioavailability: an industrial perspective.

Thomas VH, Bhattachar S, Hitchingham L, Zocharski P, Naath M, Surendran N, Stoner CL, El-Kattan A.

Expert Opin Drug Metab Toxicol. 2006 Aug;2(4):591-608. Review.

PMID:
16859407
Items per page

Supplemental Content

Loading ...
Write to the Help Desk